enalapril maleate · Azurity · NDA 208686
Epaned
Earliest generic entry, as listed
25 Mar 2036
Blocked by patent: US 10039745, US 10154987, US 10154987, US 10154987, US 10154987, US 10154987, US 10772868, US 10786482, US 11040023, US 11141405, US 11173141, US 9669008, US 9808442, US 9808442, US 9808442, US 9808442, US 9808442.
Listed patents · 17 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 10039745 | product | 25 Mar 2036 |
| US 10154987 | use U-71 | 25 Mar 2036 |
| US 10154987 | use U-1723 | 25 Mar 2036 |
| US 10154987 | use U-1892 | 25 Mar 2036 |
| US 10154987 | use U-3 | 25 Mar 2036 |
| US 10154987 | use U-185 | 25 Mar 2036 |
| US 10772868 | product | 25 Mar 2036 |
| US 10786482 | product | 25 Mar 2036 |
| US 11040023 | product | 25 Mar 2036 |
| US 11141405 | product | 25 Mar 2036 |
| US 11173141 | product | 25 Mar 2036 |
| US 9669008 | product | 25 Mar 2036 |
| US 9808442 | use U-3 | 25 Mar 2036 |
| US 9808442 | use U-1723 | 25 Mar 2036 |
| US 9808442 | use U-185 | 25 Mar 2036 |
| US 9808442 | use U-1892 | 25 Mar 2036 |
| US 9808442 | use U-71 | 25 Mar 2036 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 208686 · 001 · RLD | solution, oral | 1MG/ML | 25 Mar 2036 |